EU-SAFETY_HEALTH_WORK-PREAMBLE
EU-SAFETY_HEALTH_WORK-PREAMBLE
Safety and Health of Workers at Work Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)
This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.
Last updated 16 dubna 2024. Database contains 4691 unique substances/entries.
Filter the list
|
-
|
-
|
Acute Tox. 3 |
||
|
-
|
-
|
Acute Tox. 3 |
||
|
BLUE TZ 4312
|
423-770-3
|
-
|
Eye Dam. 1 |
|
|
423-100-1
|
-
|
Eye Dam. 1 |
||
|
TURQUOISE 10 40 518
|
411-430-7
|
-
|
Eye Dam. 1; Skin Sens. 1 |
|
|
RED JB 747
|
418-220-4
|
-
|
Skin Sens. 1 |
|
|
-
|
-
|
P Parasites |
||
|
-
|
-
|
P Parasites |
||
|
-
|
-
|
P Parasites |
||
|
-
|
-
|
P Parasites |
||
|
show/hide
Calcines, uranium ore-conc.
Calcined precipitates of ammonium, magnesium or sodium uranates obtained from natural uranium ores.
EC / List no:
297-819-0
| CAS no:
93763-02-1
Tetraammonium uranyl tricarbonate, of uranium depleted in uranium-235
EC / List no:
241-988-5
| CAS no:
18077-77-5
Dipotassium uranyl bis(sulphate), of uranium depleted in uranium-235
EC / List no:
262-284-4
| CAS no:
60542-74-7
Uranate(2-), tetrakis(acetato-O)-dioxo-, magnesium (1:1), (OC-6-11)-
EC / List no:
-
| CAS no:
66735-86-2
Sodium uranyl triacetate, of uranium depleted in uranium-235
EC / List no:
241-714-4
| CAS no:
17712-38-8
Titanate(4-), oxobis[phosphato(3-)]-, barium (1:2), uranium-doped
EC / List no:
309-550-9
| CAS no:
100403-10-9
Disodium heptaoxodiuranate, of uranium depleted in uranium-235
EC / List no:
237-286-3
| CAS no:
13721-34-1
Nickel uranyl tetraacetate, of uranium depleted in uranium-235
EC / List no:
275-994-4
| CAS no:
71767-12-9
|
-
|
-
|
Acute Tox. 2; STOT RE 2 |
|
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
P Parasites |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
show/hide
|
-
|
-
|
Carc. 1A; Acute Tox. 4; Skin Sens. 1 |
|
|
425-240-7
|
-
|
Eye Dam. 1 |
||
|
203-770-8
|
110-46-3
|
Flam. Liq. 2; Acute Tox. 4 |
||
|
430-460-1
|
133636-82-5
|
Skin Corr. 1B; Skin Sens. 1 |
||
|
606-373-1
|
197706-50-6
|
Skin Sens. 1 |
||
|
432-360-3
|
105813-13-6
|
Acute Tox. 4; Skin Sens. 1 |
||
|
BRL 29226
|
406-030-4
|
105812-81-5
|
Acute Tox. 4; Eye Dam. 1 |
|
|
214-619-0
|
1166-46-7
|
Carc. 2; Acute Tox. 4; STOT SE 2 |
||
|
KELCOR; LIPOKEL; SEQUOL
|
425-230-2
|
16610-63-2
|
Skin Corr. 1B |
|
|
-
|
115850-69-6
|
Repr. 1B; Acute Tox. 4; STOT RE 2 |
||
|
-
|
115937-89-8
|
Repr. 1B; Acute Tox. 4; STOT RE 2 |
||
|
CP-84,203-4; DFX-5S
|
411-000-9
|
125224-62-6
|
Skin Sens. 1 |
|
|
426-200-1
|
172015-79-1
|
STOT RE 1; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1 |
||
|
BLUE 10 25 964
|
407-240-9
|
159604-94-1
|
Skin Sens. 1 |
|
|
439-360-2
|
142877-45-0
|
Skin Irrit. 2; Eye Dam. 1 |
||
|
430-910-7
|
13335-71-2
|
Acute Tox. 4; Eye Dam. 1 |
||
|
BUTAMINONITRODARONE; SR33581
|
444-800-1
|
141645-23-0
|
Flam. Liq. 3; Acute Tox. 4; STOT RE 2; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 |
|
|
-
|
166900-80-7
|
Repr. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1 |
||
|
604-377-8
|
14371-10-9
|
Skin Sens. 1A |
||
|
236-232-6
|
13250-12-9
|
Flam. Liq. 2; Acute Tox. 4; Skin Corr. 1A |
||